HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koji Hayasaka Selected Research

Nausea

9/2020Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koji Hayasaka Research Topics

Disease

1Back Pain (Backache)
09/2020
1Lymphoma (Lymphomas)
09/2020
1Nausea
09/2020
1Type 2 Diabetes Mellitus (MODY)
01/2018

Drug/Important Bio-Agent (IBA)

1pegfilgrastim (Neulasta)FDA Link
09/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2018

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2020